Kazutomo Sawai | Health Professions | Best Researcher Award

Published on by Shen Awards

Dr. Kazutomo Sawai | Health Professions | Best Researcher Award

President from Hanshin Medical Co-op Daisan Clinic, Japan

Dr. Kazutomo Sawai is a distinguished Japanese physician-researcher specializing in nephrology and Kampo (traditional Japanese) medicine. He has made outstanding contributions to the understanding of glomerular regeneration, diabetic nephropathy, and molecular markers of kidney disease. With over two decades of clinical and research experience, Dr. Sawai combines modern medical science with traditional therapeutic approaches to address complex renal pathologies. His professional journey encompasses high-level academic training, fellowships at prominent institutions, and leadership roles within clinical practice and education. Since 2010, he has served as President of Daisan Clinic in Amagasaki, Hyogo, Japan, where he also champions patient education and community healthcare. Dr. Sawai’s international presence is marked by presentations at global nephrology congresses, highlighting his pivotal research on Connexin43 and Cyr61 expression in diabetic nephropathy and glomerulonephritis. His clinical insights are further enriched through his integration of Kampo medicine, reflected in his successful management of chronic cases through traditional prescriptions. A fellow of multiple Japanese medical societies, he has received notable honors for his scientific achievements. Dr. Sawai remains a committed clinician, educator, and researcher, dedicated to translational nephrology, patient-centered care, and the advancement of integrative medicine practices.

Professional Profile

Education

Dr. Kazutomo Sawai pursued his foundational medical education at the esteemed Kyoto University School of Medicine, obtaining his M.D. in 1995. Demonstrating an early interest in renal pathophysiology, he continued his academic journey by earning a Ph.D. in Renal Physiology from Kyoto University Graduate School of Medicine in 2004. His doctoral work focused on glomerular disease mechanisms and the role of angiogenic and podocyte-specific factors in kidney regeneration. Dr. Sawai’s postgraduate training included a comprehensive residency in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital between 1995 and 1997. He later undertook specialized fellowships in nephrology and dialysis therapy from 1998 to 2001 at both Saiseikai Nakatsu and Kyoto University Hospitals. Expanding his scope beyond conventional medicine, Dr. Sawai completed dual fellowships in Kampo medicine between 2015 and 2018 at Midorinokaze Clinic and Rakuwakai Otowa Hospital. This diverse academic and clinical training underpins his multidisciplinary approach to kidney care, integrating Western biomedical science with traditional Japanese therapeutics. Dr. Sawai’s strong academic background has laid a robust foundation for his research contributions and clinical leadership, positioning him as a key figure in the evolution of nephrology and holistic patient care in Japan.

Professional Experience

Dr. Sawai has cultivated an illustrious professional career marked by significant academic, clinical, and administrative roles. His early medical career began with residencies in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital from 1995 to 1997. He then specialized in nephrology and dialysis therapy during fellowships at these institutions through 2001. Dr. Sawai’s academic appointments include a role as Project Researcher in Internal Medicine at Kyoto University in 2004 and a notable tenure as Chief Researcher at the National Cardiovascular Center Research Institute in Osaka from 2004 to 2010. In 2010, he assumed the presidency of Daisan Clinic in Amagasaki, where he continues to practice, lead, and mentor. His responsibilities extend to community health, serving as Medical Director and Adviser for local home care services, and contributing as a committee member overseeing free and low-cost medical programs. He has also taught at Saiseikai Nakatsu Nursing School and Hanshin Cooperative Association Community College. With an integrated focus on internal medicine, nephrology, dialysis, and Kampo medicine, Dr. Sawai’s professional journey reflects a commitment to advancing holistic healthcare, clinical education, and community outreach.

Research Interest

Dr. Sawai’s research interests span the molecular, cellular, and clinical dimensions of nephrology. His work is particularly focused on the pathophysiology of glomerular diseases, including diabetic nephropathy, anti-GBM nephritis, and glomerulonephritis. He has extensively investigated the roles of podocyte-specific genes, such as Cyr61 (CCN1) and Connexin43, in renal injury and regeneration. These studies have led to insights into the mechanisms of podocyte dysfunction and the potential use of angiogenic and regenerative factors in predicting or improving renal outcomes. A pioneer in integrating traditional medicine into modern nephrology, Dr. Sawai has also explored the therapeutic applications of Kampo prescriptions in managing chronic symptoms such as dementia, hypertension, and neuropathic pain. His case studies highlight the efficacy of herbal formulations in complex clinical scenarios that often resist conventional treatment. His broader interest encompasses translational nephrology, where laboratory discoveries can inform clinical practice. With a comprehensive understanding of both biomedical science and traditional Japanese healing systems, Dr. Sawai’s research bridges disciplines to deliver patient-centered, evidence-based, and integrative kidney care. His continuous presence at national and international conferences further demonstrates his commitment to advancing nephrology and promoting the fusion of traditional and modern medical systems.

Research Skills

Dr. Sawai brings a sophisticated portfolio of research skills to the field of nephrology and integrative medicine. Trained in both clinical and bench research environments, he has demonstrated strong capabilities in experimental nephrology, molecular biology, and pathophysiological analysis. His core competencies include immunohistochemistry, gene expression profiling, and biomarker discovery, particularly focusing on proteins like Cyr61 and Connexin43 in renal pathology. His collaborative research has leveraged rodent models of glomerulonephritis and diabetic nephropathy to explore regeneration pathways in the kidney. Dr. Sawai’s ability to translate these findings into clinical insights distinguishes his work in translational medicine. Additionally, his skills extend to clinical trial design, retrospective case analysis, and Kampo prescription efficacy assessment, making him a rare blend of experimental and clinical researcher. He is also an experienced academic presenter and has delivered over 30 presentations at regional, national, and international conferences. His capacity for multidisciplinary collaboration, particularly in combining conventional nephrology with traditional Japanese Kampo medicine, reflects advanced integrative research skills. Through his leadership at Daisan Clinic, he continues to apply these skills in real-world settings, facilitating a seamless interface between research innovation and patient care.

Awards and Honors

Throughout his career, Dr. Kazutomo Sawai has received multiple accolades in recognition of his academic and research excellence. Among the earliest distinctions was the Miyake Memorial Award from Kyoto University Graduate School of Medicine in 2003, acknowledging his contributions to internal medicine and clinical science. In 2004, he was the recipient of the Tsujisaka Memorial Scholarship, awarded for scholarly promise and research potential in the field of renal physiology. The Young Researcher’s Award conferred at the 42nd Annual Meeting of the Japanese Society of Molecular Medicine in 2005 further highlighted his innovative work on glomerular regeneration. He also earned a Travel Grant from the American Society of Nephrology, which enabled him to present his research at international platforms and expand cross-border academic exchange. These honors not only affirm his impactful scientific work but also emphasize his contributions to the global discourse on nephrology. Dr. Sawai’s recognition by both Japanese and international institutions reflects the high quality and significance of his research. His continued academic output and interdisciplinary approach ensure that he remains at the forefront of innovation in renal medicine and integrative therapies.

Conclusion

Dr. Kazutomo Sawai stands out as a clinician-researcher of exceptional caliber, whose multifaceted career bridges the realms of nephrology, internal medicine, and Kampo therapeutics. His academic foundation at Kyoto University, combined with specialized fellowships in nephrology and traditional medicine, has shaped a unique professional identity that is both modern and rooted in tradition. As President of Daisan Clinic, he has made significant contributions to clinical nephrology while also enhancing community health services and medical education. Dr. Sawai’s research has had a profound impact on the understanding of podocyte biology, glomerular regeneration, and diabetic nephropathy, with practical applications for improving patient outcomes. His pioneering integration of Kampo medicine into nephrology offers novel approaches to managing chronic, treatment-resistant conditions. Despite a lack of editorial roles, his active participation in national and international scientific forums and multiple honors confirm his standing in the field. Dr. Sawai exemplifies dedication to science, education, and compassionate patient care, making him an ideal candidate for prestigious recognition such as the Best Researcher Award. His work continues to inspire the next generation of healthcare professionals and researchers in Japan and beyond.

Publications Top Notes

1. Traditional remedy-induced Chinese herbs nephropathy showing rapid deterioration of renal function

  • Year: 1997

  • Authors: Tanaka A, Nishida R, Sawai K, Nagae T, Shinkai S, Ishikawa M, Maeda K, Murata M, Seta K, Okuda J, Yoshida T, Sugawara A, Kuwahara T

  • Journal: Nihon Jinzo Gakkai Shi

2. Human parvovirus B19 infection resembling systemic lupus erythematosus

  • Year: 1998

  • Authors: Tanaka A, Sugawara A, Sawai K, Kuwahara T

  • Journal: Intern Med

3. Concealed hypothyroidism in patients with myeloperoxidase antineutrophil cytoplasmic autoantibodies (MPO-ANCA) positive renal disease

  • Year: 1999

  • Authors: Tanaka A, Maeda K, Sawai K, Okuda J, Sugawara A, Kuwahara T

  • Journal: Clinical Nephrology

4. Intraglomerular metastasis from pancreatic cancer

  • Year: 2001

  • Authors: Yokoi H, Nakata M, Sawai K, Yoshida T, Koshikawa M, Joyama S, Tanaka A, Goto M, Ueda S, Senzaki H, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

5. C4d and C4bp deposition along the glomerular capillary walls in a patient with preeclampsia

  • Year: 2001

  • Authors: Joyama S, Yoshida T, Koshikawa M, Sawai K, Yokoi H, Tanaka A, Gotoh M, Ueda S, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

6. Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis

  • Year: 2003

  • Authors: Sawai K, Mori K, Mukoyama M, Sugawara A, Suganami T, Koshikawa M, Yahata K, Makino H, Nagae T, Fujinaga Y, Yokoi H, Yoshioka T, Yoshimoto A, Tanaka I, Nakao K

  • Journal: Journal of the American Society of Nephrology

7. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis

  • Year: 2004

  • Authors: Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa M, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

8. Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy

  • Year: 2005

  • Authors: Suganami T, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Sawai K, Hidaka S, Ebihara K, Tanaka T, Sugawara A, Kawachi H, Vinson C, Ogawa Y, Nakao K

  • Journal: FASEB Journal

9. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury

  • Year: 2005

  • Authors: Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J

  • Journal: Journal of Clinical Investigation

10. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome

  • Year: 2005

  • Authors: Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Dr. Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, United States

Dr. Guanbo Wang is a distinguished postdoctoral research fellow at the CAUSALab, Harvard T.H. Chan School of Public Health. With a robust background in biostatistics and epidemiology, his work primarily focuses on developing innovative statistical methodologies to enhance causal inference in public health research. Dr. Wang’s expertise lies in integrating complex data sources to derive meaningful insights into treatment effects, particularly in the context of randomized clinical trials and observational studies. His interdisciplinary approach combines rigorous statistical theory with practical applications, aiming to inform clinical decision-making and health policy. Throughout his academic and professional journey, Dr. Wang has demonstrated a commitment to advancing public health through methodological innovation and collaborative research.

Professional Profile

Education

Dr. Wang’s academic journey commenced with a Bachelor of Science degree from China Textile University in Shanghai, China, in 1999. He pursued further studies at Shanghai Jiao Tong University, earning a Master of Science in 2002 and a Ph.D. in 2005. His doctoral research laid the foundation for his future endeavors in biostatistics and epidemiology. In 2019, Dr. Wang expanded his academic horizons as a visiting scholar at Harvard University, engaging with leading experts in the field. He culminated his formal education with a Ph.D. in Biostatistics from McGill University in 2022, where he honed his skills in statistical modeling and causal inference. Dr. Wang’s comprehensive educational background equips him with the theoretical knowledge and practical expertise necessary for his contributions to public health research.

Professional Experience

Dr. Wang’s professional experience encompasses a blend of academic research and industry collaboration. From 2015 to 2022, he served as a research assistant at McGill University and the McGill University Health Centre Research Institute, contributing to various projects in biostatistics and epidemiology. His industry experience includes internships and consultancy roles at prominent organizations such as Biogen, Roche, Baker & McKenzie, FINEOS Co., Ltd., KPMG China, and AXA Insurance Group. These roles provided Dr. Wang with practical insights into the application of statistical methods in diverse settings, including pharmaceuticals, legal consulting, and insurance. In 2023, he collaborated with the Center for Biostatistics in AIDS Research (CBAR), further solidifying his expertise in clinical trial analysis. Dr. Wang’s multifaceted professional background reflects his adaptability and commitment to applying statistical methodologies to real-world challenges.

Research Interests

Dr. Wang’s research interests are centered on advancing causal inference methodologies to address complex questions in public health. He focuses on data integration techniques that allow for the extension of causal inferences across different populations and data sources. His work on treatment effect heterogeneity aims to identify subpopulations that may benefit differently from interventions, thereby informing personalized medicine approaches. Dr. Wang also explores innovative trial designs, including adaptive and Bayesian frameworks, to enhance the efficiency and ethical conduct of clinical studies. Additionally, he is interested in incorporating prior knowledge, such as expert opinions, into statistical models to improve their interpretability and relevance. His methodological contributions are applied across various disease areas, including cardiovascular diseases, cancer, infectious diseases, and mental health disorders.

Research Skills

Dr. Wang possesses a comprehensive skill set in statistical methodologies and data analysis. His expertise includes nonparametric and semiparametric statistics, machine learning, high-dimensional data analysis, survival analysis, and optimization techniques. He is proficient in handling complex data structures, such as time-dependent treatments and longitudinal outcomes, commonly encountered in clinical and observational studies. Dr. Wang is adept at utilizing programming languages like R, Python, and C++ for statistical computing and developing analytical tools. His experience spans various data sources, including randomized clinical trials, electronic health records, and administrative databases. This diverse skill set enables him to tackle intricate research questions and contribute to methodological advancements in public health.

Awards and Honors

Dr. Wang’s contributions to biostatistics and public health research have been recognized through numerous awards and honors. He received the Fonds de Recherche du Québec – Santé Doctoral Training Grant (2019-2022), acknowledging his potential in health research. In 2021, he was honored with the Centre de Recherches Mathématiques StatLab Graduate Award and the McGill GREAT Award, reflecting his academic excellence. His achievements also include the McGill Graduate Excellence Award (2016-2021), the McGill Mobility Award (2019), and the McGill University Health Centre Studentship Fellowship (2019). Additionally, he was awarded the Statistical Society of Canada Biostatistics Travel Award in 2018. These accolades underscore Dr. Wang’s dedication to advancing statistical methodologies and their application in public health.

Conclusion

Dr. Guanbo Wang exemplifies a commitment to enhancing public health through methodological innovation in biostatistics and epidemiology. His extensive education and diverse professional experiences have equipped him with a robust foundation to address complex health research questions. Dr. Wang’s research endeavors aim to refine causal inference techniques, improve clinical trial designs, and integrate diverse data sources for comprehensive analyses. His contributions have the potential to inform evidence-based decision-making and personalized healthcare strategies. As he continues his work at the CAUSALab, Dr. Wang remains at the forefront of developing statistical methodologies that bridge the gap between data and impactful public health interventions.

Publications Top Notes

  1. Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis
    Authors: A.A. Siddique, M.E. Schnitzer, A. Bahamyirou, G. Wang, T.H. Holtz, G.B. Migliori, et al.
    Journal: Statistical Methods in Medical Research, 28(12), 3534–3549
    Year: 2019
    Citations: 31

  1. Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis
    Authors: G. Wang, M.E. Schnitzer, D. Menzies, P. Viiklepp, T.H. Holtz, A. Benedetti
    Journal: Biometrics, 76(3), 1007–1016
    Year: 2020
    Citations: 17

  2. Using Effect Scores to Characterize Heterogeneity of Treatment Effects
    Authors: G. Wang, P.J. Heagerty, I.J. Dahabreh
    Journal: Journal of the American Medical Association
    Year: 2024
    Citations: 16

  1. Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patient data meta-analysis
    Authors: Y. Liu, M.E. Schnitzer, G. Wang, E. Kennedy, P. Viiklepp, M.H. Vargas, et al.
    Journal: Statistical Methods in Medical Research, 31(4), 689–705
    Year: 2022
    Citations: 10

  2. Evaluating hybrid controls methodology in early-phase oncology trials: A simulation study based on the MORPHEUS-UC trial
    Authors: G. Wang, M.P. Costello, H. Pang, J. Zhu, H.J. Helms, I. Reyes-Rivera, R.W. Platt, et al.
    Journal: Pharmaceutical Statistics, 23(1), 31–45
    Year: 2023
    Citations: 8

  3. Predictive factors of detectable viral load in HIV-infected patients
    Authors: A. Bouchard, F. Bourdeau, J. Roger, V.T. Taillefer, N.L. Sheehan, M. Schnitzer, G. Wang, et al.
    Journal: AIDS Research and Human Retroviruses, 38(7), 552–560
    Year: 2022
    Citations: 8

  4. Penalized G-estimation for effect modifier selection in the structural nested mean models for repeated outcomes
    Authors: A. Jaman, G. Wang, A. Ertefaie, M. Bally, R. Lévesque, R. Platt, M. Schnitzer
    Journal: Biometrics, 81(1)
    Year: 2024
    Citations: 5

  5. Robust integration of external control data in randomized trials
    Authors: G. Wang, R. Karlsson, J.H. Krijthe, I.J. Dahabreh
    Journal: arXiv preprint, arXiv:2406.17971
    Year: 2024
    Citations: 4

  1. Association between Sitting Time and Urinary Incontinence in the US Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2007 to 2018
    Authors: D. Xingpeng, Y. Chi, X. Liyuan, W. Guanbo, L. Banghua
    Journal: Heliyon, 10(6)
    Year: 2024
    Citations: 4

  1. Integrating complex selection rules into the latent overlapping group Lasso for constructing coherent prediction models
    Authors: G. Wang, S. Perreault, R.W. Platt, R. Wang, M. Dorais, M.E. Schnitzer
    Journal: Statistics in Medicine
    Year: 2025
    Citations: 3

 

Huan-You Wang | Health Professions | Best Academic Researcher Award

Published on by Shen Awards

Prof. Huan-You Wang | Health Professions | Best Academic Researcher Award

Professor of Pathology, Director of Hematopathology Fellowship, Associate Vice Chair for Education and Academic Affairs, University of California San Diego, United States

Dr. Huan-You Wang is a distinguished Clinical Professor of Pathology at the University of California, San Diego (UCSD), where he also serves as the Medical Director of the Clinical Hematology Laboratory. With an extensive career in academic medicine and clinical diagnostics, Dr. Wang has made significant contributions to the field of hematopathology. His research primarily focuses on hematologic malignancies, including leukemia, lymphoma, and myelodysplastic syndromes. Dr. Wang’s expertise encompasses molecular diagnostics, flow cytometry, and the integration of advanced genomic techniques into clinical practice. He has authored over 160 peer-reviewed publications, reflecting his commitment to advancing medical knowledge and improving patient care. Beyond his clinical and research endeavors, Dr. Wang has played a pivotal role in medical education, mentoring numerous trainees and contributing to the development of pathology fellowship programs at UCSD. His leadership extends to professional organizations, having served as the President of the Chinese American Pathologists Association (CAPA) from 2019 to 2020. Dr. Wang’s dedication to excellence in pathology has earned him recognition as a leader in his field, influencing both national and international practices in hematopathology.

Professional Profile

Education

Dr. Wang’s academic journey began at Tongji Medical University in Wuhan, China, where he served as a Graduate Research Associate in the Department of Pathology from 1987 to 1990. He then held an instructor position at Peking University Health Sciences Center in Beijing from 1990 to 1992. Pursuing advanced education, Dr. Wang completed his MD and PhD at the University of California, San Diego, specializing in Molecular Pathology and Cellular and Molecular Medicine between 1994 and 2000. This rigorous training provided him with a robust foundation in both clinical medicine and biomedical research, equipping him with the skills necessary to excel in the complex field of hematopathology. His educational background reflects a blend of international experience and interdisciplinary expertise, contributing to his comprehensive approach to pathology and research.

Professional Experience

Dr. Wang’s professional career is marked by a series of esteemed positions in academic and clinical settings. From 2005 to 2009, he served as an Assistant Professor of Pathology at the University of Texas Southwestern Medical Center in Richardson, Texas. In 2009, he joined the University of California, San Diego, where he currently holds the position of Clinical Professor of Pathology. At UCSD, Dr. Wang also serves as the Medical Director of the Clinical Hematology Laboratory, overseeing diagnostic services and contributing to the advancement of laboratory practices. His roles have encompassed clinical diagnostics, research, and education, reflecting a commitment to integrating scientific discovery with patient care. Dr. Wang’s leadership in these capacities has significantly influenced the development of pathology services and the training of future medical professionals.

Research Interests

Dr. Wang’s research interests are centered on the pathogenesis and diagnosis of hematologic malignancies. He has extensively studied various forms of leukemia and lymphoma, focusing on the molecular and cellular mechanisms underlying these diseases. His work often involves the application of advanced techniques such as flow cytometry, molecular diagnostics, and genomic analysis to improve diagnostic accuracy and patient outcomes. Dr. Wang is particularly interested in the identification of novel biomarkers and therapeutic targets, aiming to enhance personalized medicine approaches in hematopathology. His research contributes to a deeper understanding of disease processes and the development of innovative diagnostic and treatment strategies.

Research Skills

Dr. Wang possesses a comprehensive skill set that encompasses various methodologies essential to modern pathology research. His expertise includes flow cytometry, which he utilizes for immunophenotypic analysis of hematologic malignancies. He is proficient in molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), enabling the detection of genetic mutations and chromosomal abnormalities. Dr. Wang also employs immunohistochemistry for the characterization of tissue samples, contributing to accurate disease classification. His skills extend to the interpretation of complex data sets, integrating clinical findings with laboratory results to inform diagnostic and therapeutic decisions. This multifaceted expertise allows Dr. Wang to conduct comprehensive research that bridges laboratory science and clinical application.

Awards and Honors

Throughout his career, Dr. Wang has received numerous accolades recognizing his contributions to pathology and medical research. Notably, he served as the President of the Chinese American Pathologists Association (CAPA) from 2019 to 2020, reflecting his leadership and commitment to the professional community. His extensive publication record, comprising over 160 peer-reviewed articles, underscores his influence in the field and dedication to advancing scientific knowledge. Dr. Wang’s work has garnered citations and recognition from peers, highlighting the impact of his research on the understanding and management of hematologic diseases. These honors attest to his role as a leading figure in pathology, contributing to both academic excellence and clinical innovation.

Conclusion

Dr. Huan-You Wang’s career exemplifies a harmonious blend of clinical practice, research, and education in the field of pathology. His dedication to understanding hematologic malignancies has led to significant advancements in diagnostic methodologies and patient care. Through his leadership roles, including his tenure as President of CAPA, Dr. Wang has influenced the direction of pathology practice and fostered professional development within the community. His commitment to mentorship and education ensures the cultivation of future experts in the field. Dr. Wang’s contributions continue to shape the landscape of hematopathology, reflecting a career devoted to scientific inquiry, clinical excellence, and the betterment of patient outcomes.

Publications Top Notes

  1. Title: Isolated Monoclonal T-Cell Receptor Gene Rearrangement in a Lung Adenocarcinoma Harboring MET Exon 14 Skipping: Diagnostic Pitfall
    Authors: Shi, Wangpan Jackson; Nguyen, Joshua J.; Song, Wei W.; Fadare, Oluwole O.; Lei, Li L.
    Journal: International Journal of Surgical Pathology
    Year: 2025

  2. Title: Intratumoral Injection of Cytotoxic Drugs Plus Hapten Elicits Significant Immune Responses in Sentinel Lymph Nodes: Implications for Cancer Immunotherapy
    Authors: Yu, Baofa B.; Zhang, Jian J.; Han, Yan Y.; Zhou, Shengjun S.; Wang, Huanyou H.
    Journal: Pancreas
    Year: 2025

  3. Title: Erythroblastic Sarcoma in Adults and Children: Different Pathways to the Same Destination
    Authors: Fitzpatrick, Megan J.; Yuan, Ji J.; Capa, Ioana I.; Medeiros, Leonard Jeffrey L.; Pan, Zenggang Z.
    Journal: Modern Pathology
    Year: 2025

  4. Title: Mutation in Bruton Tyrosine Kinase (BTK) A428D Confers Resistance to BTK-Degrader Therapy in Chronic Lymphocytic Leukemia
    Authors: Wong, Richard L.; Choi, Michael Youngjun M.Y.; Wang, Huanyou H.; Kipps, Thomas J.
    Type: Letter
    Year: 2025
    Citations: 9

  5. Title: A CD10-Negative Adult B-Lymphoblastic Leukemia with Amplification of KMT2A Without Rearrangement: A Case Report and Review of the English Literature
    Authors: Wang, Huanyou H.; Louis, Hailee M.St H.M.S.; Costello, Caitlin L.C.L.; Murray, Sarah Shaw S.S.; Dell’Aquila, Marie L.M.L.
    Year: 2025

  6. Title: Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract—What Have We Learned in the Last Decade?
    Authors: Wang, Xingen X.; Yin, Weihua W.; Wang, Huanyou H.
    Type: Review
    Year: 2025

  7. Title: Nuclear Morphology is Shaped by Loop-Extrusion Programs
    Authors: Patta, Indumathi I.; Zand, Maryam M.; Lee, Lindsay L.; Hu, Ming M.; Murre, Cornelis C.
    Journal: Nature
    Year: 2024
    Citations: 3

  8. Title: IDH2-Mutated Near ETP-ALL with Aggressive Leukemia Cutis and Brisk Response to Venetoclax and Decitabine
    Authors: Vaidya, Poorva P.; Wang, Huanyou H.; Don, Michelle D.M.D.; Hinds, Brian R.B.R.; Mangan, James K.J.K.
    Journal: Leukemia Research Reports
    Year: 2024
    Citations: 1

  9. Title: Myeloid Lineage Switch Following CD7-Targeted Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia
    Authors: Aldoss, Ibrahim T.I.T.; Tizro, Parastou P.; Bedi, Davsheen D.; Wang, Huanyou H.; Afkhami, Michelle M.
    Journal: Haematologica
    Year: 2023
    Citations: 3

  10. Title: A Cell-Level Discriminative Neural Network Model for Diagnosis of Blood Cancers
    Authors: Robles, Edgar E.E.; Jin, Ye Y.; Smyth, Padhraic P.; Oak, Jean S.J.S.; Qian, Yu Y.
    Journal: Bioinformatics
    Year: 2023
    Citations: 4

Recinda Sherman | Health Professions | Best Researcher Award

Published on by Shen Awards

Dr. Recinda Sherman | Health Professions | Best Researcher Award

North American Association of Central Cancer Registries (NAACCR), United States

Dr. Recinda L. Sherman is a distinguished public health professional specializing in cancer surveillance and epidemiology. She currently serves as the Program Manager of Data Use and Research at the North American Association of Central Cancer Registries (NAACCR), where she oversees the development and dissemination of cancer data products, including the CiNA (Cancer in North America) data series . With a PhD and MPH, Dr. Sherman has a robust academic background that underpins her extensive experience in managing large-scale cancer data and contributing to public health research. Her work is pivotal in informing cancer control strategies and health policy decisions across North America.

Professional Profile

Education

Dr. Sherman holds a Doctor of Philosophy (PhD) and a Master of Public Health (MPH), reflecting her deep academic engagement in public health and epidemiology. Her educational journey has equipped her with the expertise necessary for high-level research and data analysis in cancer surveillance. Additionally, she is a Certified Tumor Registrar (CTR), a credential that underscores her proficiency in cancer data collection and registry operations . Her academic and professional qualifications have been instrumental in her contributions to cancer epidemiology and public health initiatives.

Professional Experience

In her role at NAACCR, Dr. Sherman manages data use and research programs, focusing on the quality and utility of cancer registry data. She has been involved in various projects aimed at improving cancer data collection and analysis, including the development of best practices for geocoding in cancer registries . Her professional experience also includes serving as an adjunct professor at Claremont Graduate University, where she contributes to the academic development of future public health professionals . Dr. Sherman’s career reflects a commitment to enhancing cancer surveillance and fostering research that informs public health policy.

Research Interests

Dr. Sherman’s research interests encompass cancer epidemiology, spatial analysis, and health disparities. She has authored numerous publications that explore patterns in cancer incidence and mortality, with a particular focus on geographic and demographic disparities . Her work often involves the application of geospatial techniques to understand the distribution of cancer cases and to identify areas in need of targeted public health interventions. Dr. Sherman’s research contributes to a deeper understanding of the factors influencing cancer outcomes and supports the development of strategies to address inequities in cancer care.

Research Skills

Dr. Sherman possesses a comprehensive skill set in epidemiological research, including expertise in cancer surveillance, spatial epidemiology, and public health data analysis. Her proficiency in geocoding and GIS applications enables her to conduct detailed spatial analyses of cancer data, which are crucial for identifying trends and informing public health strategies . Additionally, her experience in managing large datasets and her knowledge of cancer registry operations position her as a leader in the field of cancer epidemiology. Dr. Sherman’s research skills are integral to her contributions to public health research and policy development.

Awards and Honors

Dr. Sherman’s contributions to cancer epidemiology and public health have been recognized through various awards and honors. While specific accolades are not detailed in the available sources, her leadership role at NAACCR and her involvement in significant research projects underscore her standing in the field. Her work has been instrumental in advancing cancer surveillance practices and in promoting the use of high-quality data for public health decision-making. Dr. Sherman’s professional achievements reflect her dedication to improving cancer outcomes and her impact on public health research.​

Conclusion

Dr. Recinda L. Sherman is a prominent figure in cancer epidemiology, with a career dedicated to enhancing cancer surveillance and informing public health policy. Her academic background, professional experience, and research expertise have positioned her as a leader in the field. Through her work at NAACCR and her academic contributions, Dr. Sherman continues to influence the collection and analysis of cancer data, supporting efforts to reduce cancer disparities and improve health outcomes. Her commitment to public health and her contributions to cancer research exemplify the critical role of epidemiologists in advancing healthcare.

Publications Top Notes

  1. Cancer incidence among Marines and Navy personnel and civilian workers exposed to industrial solvents in drinking water at US Marine Corps Base Camp Lejeune: A cohort study
    Authors: Frank J. Bove, April A. Greek, Ruth Gatiba, Gene T. Shin, Aaron Bernstein
    Journal: Environmental Health Perspectives
    Year: 2024
    Citations: 1

  2. Annual Report to the Nation on the Status of Cancer, Part 2: Early assessment of the COVID-19 pandemic’s impact on cancer diagnosis
    Authors: Serban Negoita, Huann Sheng Chen, Pamela V. Sanchez, Ahmedin M. Jemal, Kathleen A. Cronin
    Journal: Cancer
    Year: 2024
    Citations: 24

  3. Annual Report to the Nation on the Status of Cancer, Part 1: National cancer statistics
    Authors: Kathleen A. Cronin, Susan M. Scott, Albert U. Firth, William G. Cance, Ahmedin M. Jemal
    Journal: Cancer
    Year: 2022
    Citations: 308

  4. Annual Report to the Nation on the Status of Cancer, Part 2: Patient economic burden associated with cancer care
    Authors: Robin Yabroff, Ângela B. Mariotto, Florence K.L. Tangka, Ahmedin M. Jemal, Elizabeth M. Ward
    Journal: Journal of the National Cancer Institute
    Year: 2021
    Citations: 126

  5. Annual Report to the Nation on the Status of Cancer, Part 1: National cancer statistics
    Authors: Farhad Islami, Elizabeth M. Ward, Hyuna Sung, Robin Yabroff, Vicki B. Benard
    Journal: Journal of the National Cancer Institute
    Year: 2021
    Citations: 354

​

Vimala Ramoo | Health Professions | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Vimala Ramoo | Health Professions | Best Researcher Award

Associate Professor from Universiti Malaya, Malaysia

Dr. Vimala A/P Ramoo is a distinguished academic and healthcare professional known for her expertise in gerontological nursing, patient safety, and clinical decision-making. With a strong background in nursing practice and education, Dr. Vimala has contributed extensively to healthcare research and nursing curricula in Malaysia and beyond. She holds a prominent position at the University of Malaya and has been instrumental in shaping policy and practice standards within the nursing profession. Dr. Vimala’s scholarly work often focuses on improving the quality of care for older adults, exploring complex clinical situations, and fostering evidence-based nursing interventions. She is widely recognized for her leadership in multidisciplinary research teams and her dedication to mentoring emerging nursing scholars. Her publications in peer-reviewed journals reflect her commitment to enhancing nursing practices through scientific inquiry. Beyond academia, Dr. Vimala is actively involved in outreach and advocacy, striving to elevate the standards of elder care in both institutional and community settings. Her balanced approach to education, practice, and research has garnered her a reputation as a leading voice in Malaysian nursing. With a blend of clinical insight and academic rigor, Dr. Vimala continues to influence health care delivery and nursing education across Southeast Asia.

Professional Profile

Education

Dr. Vimala A/P Ramoo’s academic journey is rooted in a strong foundation in nursing and health sciences. She began her higher education with a Bachelor of Nursing Science degree, equipping her with clinical proficiency and foundational knowledge in patient care. Driven by a passion for continuous learning and academic excellence, she pursued a Master’s degree in Nursing, where she specialized in gerontology and clinical care practices. Her master’s thesis focused on aging populations and patient safety—topics that would later define her research career. Furthering her academic pursuits, Dr. Vimala earned a Ph.D. in Nursing from the University of Malaya, one of Malaysia’s leading research institutions. Her doctoral research emphasized the decision-making processes of nurses in critical care environments, highlighting factors that influence safe and effective patient outcomes. In addition to her formal education, Dr. Vimala has participated in various professional development programs and international workshops related to health education, leadership in nursing, and qualitative research methodologies. These educational experiences not only enhanced her academic qualifications but also shaped her as a researcher, educator, and practitioner. Her educational background laid the groundwork for her impactful contributions to nursing research, particularly in the areas of geriatric care, clinical ethics, and evidence-based nursing practices.

Professional Experience

Dr. Vimala A/P Ramoo brings over two decades of professional experience in nursing, health education, and academic leadership. She currently serves as a senior lecturer at the Faculty of Medicine, University of Malaya, where she teaches undergraduate and postgraduate nursing students. In her academic role, Dr. Vimala designs and delivers coursework in gerontological nursing, patient safety, and clinical decision-making, ensuring students are equipped with the latest knowledge and evidence-based practices. Before transitioning fully into academia, she held various clinical positions in both public and private healthcare settings, where she gained hands-on experience in critical care and elder health services. Her clinical background gives her teaching and research a practical, grounded perspective. In addition to her academic duties, Dr. Vimala plays a key role in departmental committees, research ethics boards, and curriculum development initiatives. She has also served as a research mentor and thesis supervisor to numerous postgraduate students. Her collaborations with interdisciplinary teams extend to national healthcare policy discussions and advisory panels. Through her dual focus on education and practice, Dr. Vimala bridges the gap between nursing theory and application, making her a valuable asset to both the academic and healthcare communities in Malaysia.

Research Interests

Dr. Vimala A/P Ramoo’s research interests lie at the intersection of nursing care, patient safety, and gerontology. Her work focuses on improving healthcare delivery for older adults by exploring clinical decision-making processes, communication in nursing teams, and ethical considerations in caregiving. One of her primary interests is the development of safe and effective nursing practices in long-term care settings, particularly within multicultural and resource-limited contexts. Dr. Vimala also investigates how organizational culture and nurse-patient interactions influence the quality of care and patient outcomes. Her research often adopts qualitative and mixed-method approaches to understand complex human experiences in healthcare environments. Another significant aspect of her work includes examining the role of nurse education in shaping patient safety behavior and clinical competence among nurses. She has contributed to projects on fall prevention, palliative care, and dementia care strategies, aiming to enhance the well-being and dignity of aging populations. Dr. Vimala is deeply interested in advancing evidence-based practices through interdisciplinary collaboration, integrating perspectives from medicine, social work, and public health. Her research not only contributes to scholarly literature but also has direct implications for policy-making, nursing education reforms, and improved standards of geriatric healthcare services.

Research Skills

Dr. Vimala A/P Ramoo possesses a diverse range of research skills that reflect her deep engagement with nursing science and health services research. She is proficient in both qualitative and quantitative research methodologies, with particular expertise in ethnography, phenomenology, and grounded theory. These approaches allow her to explore the lived experiences of patients, caregivers, and healthcare professionals in depth. She is also skilled in statistical analysis and the use of software tools such as SPSS and NVivo, which she employs for data analysis and thematic coding. Dr. Vimala is adept at designing research frameworks, developing validated survey instruments, and conducting literature reviews that support evidence-based practice. Her project management skills are evident in her successful coordination of multidisciplinary research grants and collaborative studies. Furthermore, she has extensive experience in academic writing, publishing in high-impact peer-reviewed journals, and presenting at international conferences. Dr. Vimala is also involved in supervising graduate students and mentoring early-career researchers, enhancing the overall research capacity within her department. Her strong ethical grounding, coupled with an ability to translate research findings into practical interventions, makes her a leader in healthcare research focused on gerontology, clinical decision-making, and nursing education.

Awards and Honors

Dr. Vimala A/P Ramoo has been the recipient of numerous awards and honors in recognition of her outstanding contributions to nursing education and research. Her achievements reflect her commitment to excellence, innovation, and service in the healthcare and academic sectors. Among her most notable accolades is the Excellence in Teaching Award from the University of Malaya, which acknowledges her exceptional performance as an educator and mentor. She has also received Best Research Presentation Awards at several national and international conferences, highlighting the significance and impact of her scholarly work. Dr. Vimala’s research projects have been supported through competitive grants, further affirming her credibility and leadership in nursing research. In addition, she has been invited as a keynote speaker and panelist at global health forums and nursing symposia, underlining her influence and thought leadership in the field. Her work on elder care and patient safety has garnered recognition from professional nursing bodies and government-linked health agencies. These honors not only affirm her individual accomplishments but also underscore her broader impact on improving nursing standards and education in Malaysia and the region. Dr. Vimala continues to be a role model for nurses and scholars aspiring to make meaningful contributions to healthcare.

Conclusion

Dr. Vimala A/P Ramoo stands as a pioneering figure in Malaysian nursing, blending academic excellence, clinical experience, and research innovation to transform healthcare education and practice. Her unwavering commitment to gerontological nursing and patient safety has significantly influenced the quality of care provided to aging populations. Through her roles as an educator, researcher, and clinician, she continues to bridge the gap between theory and practice, ensuring that nursing students are well-prepared to meet the evolving challenges of modern healthcare. Her scholarly contributions, particularly in clinical decision-making and ethical caregiving, offer valuable insights that inform policy and improve patient outcomes. Beyond her academic pursuits, Dr. Vimala is an advocate for equity and compassion in healthcare, promoting culturally sensitive and patient-centered practices. Her mentorship has inspired a new generation of nursing professionals, and her leadership continues to elevate the nursing profession in Southeast Asia. With a career marked by integrity, innovation, and impact, Dr. Vimala remains a respected and influential voice in both national and international healthcare circles. Her ongoing work is not only shaping the future of nursing in Malaysia but also contributing to global conversations on quality healthcare, elder care, and nursing education.

Publications Top Notes

  1. Title: The relationship between job satisfaction and intention to leave current employment among registered nurses in a teaching hospital
    Authors: V. Ramoo, K.L. Abdullah, C.Y. Piaw
    Year: 2013
    Citations: 237

  2. Title: Escalating progression of mental health disorders during the COVID-19 pandemic: Evidence from a nationwide survey
    Authors: L.P. Wong, H. Alias, A.A. Md Fuzi, I.S. Omar, A. Mohamad Nor, M.P. Tan, …
    Year: 2021
    Citations: 164

  3. Title: Educational intervention on delirium assessment using confusion assessment method‐ICU (CAM‐ICU) in a general intensive care unit
    Authors: V. Ramoo, H. Abu, V. Rai, S.K. Surat Singh, A.A. Baharudin, M. Danaee, …
    Year: 2018
    Citations: 76

  4. Title: Knowledge, attitude and practice in relation to catheter‐associated urinary tract infection (CAUTI) prevention: A cross‐sectional study
    Authors: I. Mong, V. Ramoo, S. Ponnampalavanar, M.C. Chong, W.N.F. Wan Nawawi
    Year: 2022
    Citations: 48

  5. Title: Missed nursing care in the Malaysian context: A cross‐sectional study from nurses’ perspective
    Authors: S.T. Nahasaram, V. Ramoo, W.L. Lee
    Year: 2021
    Citations: 35

  6. Title: Nursing practice environment, resilience, and intention to leave among critical care nurses
    Authors: L.Y. Ying, V. Ramoo, L.W. Ling, S.T. Nahasaram, C.P. Lei, L.K. Leong, …
    Year: 2021
    Citations: 34

  7. Title: The impact of organisational communication satisfaction on health care professionals’ work engagement
    Authors: H.J. Abu Dalal, V. Ramoo, M.C. Chong, M. Danaee, Y.I. Aljeesh
    Year: 2022
    Citations: 31

  8. Title: The relationship between psychological distress and religious practices and coping in Malaysian parents of children with thalassemia
    Authors: L.T. Chong, M.C. Chong, L.Y. Tang, V. Ramoo, P.L. Chui, N.T.T. Hmwe
    Year: 2019
    Citations: 30

  9. Title: Intervention to improve intensive care nurses’ knowledge of sedation assessment and management
    Authors: V. Ramoo, K.L. Abdullah, P.S.K. Tan, L.P. Wong, P.Y. Chua
    Year: 2016
    Citations: 30

  10. Title: Challenges for healthcare workers caring for COVID-19 patients in Indonesia: a qualitative study
    Authors: H.W. Setiawan, I.N. Pratiwi, L. Nimah, Z. Pawanis, A. Bakhtiar, …
    Year: 2021
    Citations: 29

  11. Title: Career maturity, psychological resilience, and professional self-concept of nursing students in China: A nationwide cross-sectional study
    Authors: F.F. Lyu, V. Ramoo, Y.X. Wang
    Year: 2022
    Citations: 27

  12. Title: Sedation scoring and managing abilities of intensive care nurses post educational intervention
    Authors: V. Ramoo, K.L. Abdullah, P.S.K. Tan, L.P. Wong, Y.P. Chua, L.Y. Tang
    Year: 2017
    Citations: 21

Karolini Branco | Health Professions | Best Researcher Award

Published on by Shen Awards

Mrs. Karolini Branco | Health Professions | Best Researcher Award

PhD student from Cardiology Institute of Rio Grande do Sul, Brazil

Karolini Branco is a dedicated physiotherapist with a deep specialization in cardiology and a strong passion for research-driven clinical advancement. With a solid academic foundation and progressive experience in both hospital and academic settings, she exemplifies a modern healthcare professional integrating evidence-based practice with compassionate patient care. Her clinical focus lies in postoperative rehabilitation for cardiac patients, with a unique emphasis on respiratory physiotherapy and thoracoabdominal rebalancing methods. Currently pursuing a PhD in Health Sciences: Cardiology, she is actively involved in research that enhances recovery outcomes for patients undergoing coronary artery bypass grafting and other major cardiac procedures. Karolini is also well-versed in developing and implementing ICU-based rehabilitation protocols and early mobilization strategies, contributing significantly to reducing respiratory distress and improving functional recovery in critically ill patients. Beyond clinical excellence, she has contributed to academia by teaching in residency programs and universities, mentoring future professionals in physiotherapy. Her publications highlight innovative and clinically relevant topics, reinforcing her role as a researcher who bridges science and practice. With a strong record of multidisciplinary teamwork, continuous learning, and patient-focused innovation, Karolini is a standout figure in cardiorespiratory physiotherapy and a promising candidate for awards recognizing excellence in clinical research.

Professional Profile

Education

Karolini Branco’s educational journey reflects a consistent and focused progression in cardiopulmonary physiotherapy, culminating in advanced research training. She began her academic career with a Bachelor’s degree in Physiotherapy from the Centro Universitário Cenecista de Osório (2014–2018), where she laid the foundational knowledge in physical therapy sciences. Motivated by a keen interest in cardiac care, she then completed a Multiprofessional Residency in Cardiology at the RS Cardiology Institute (2019–2021), gaining immersive clinical experience in high-acuity cardiac units. Her academic rigor and growing research interest led her to pursue a Master’s degree in Health Sciences: Cardiology (2021–2023), also at the RS Cardiology Institute. Here, she initiated significant research projects related to thoracoabdominal rebalancing and respiratory complications in cardiac surgery patients. Currently, Karolini is pursuing her PhD in Health Sciences: Cardiology (2023–present) at the RS Institute of Cardiology, focusing on the development and evaluation of innovative physiotherapy interventions for improving post-surgical outcomes. Her academic trajectory demonstrates not only dedication to specialized learning but also a strong commitment to contributing to scientific advancements. Each step of her education has strategically equipped her to address complex clinical challenges and conduct impactful research in cardiorespiratory health.

Professional Experience

Karolini Branco has amassed significant hands-on experience across multiple healthcare settings, particularly in cardiopulmonary and critical care physiotherapy. Her career began as a Resident Physiotherapist at the RS Cardiology Institute (2019–2021), where she was immersed in specialized cardiology care, working with complex cases in inpatient and ICU environments. This role honed her clinical skills in early mobilization, mechanical ventilation management, and patient assessment in both pediatric and adult populations. Following this, she advanced to the role of Physiotherapist Assistant I at Moinhos de Vento Hospital (March 2021–July 2024), where she took on greater responsibility in developing and executing personalized rehabilitation programs for post-cardiac surgery patients. Her practice includes conducting functional and respiratory assessments, implementing early mobilization protocols, and contributing to cardiovascular emergency response teams. Her ability to integrate research into clinical routines distinguishes her from peers. Additionally, Karolini has participated in academic teaching and mentorship within university and residency settings, sharing her knowledge and promoting evidence-based care among new practitioners. Her professional journey reflects a well-rounded clinician who thrives in high-pressure environments, is committed to multidisciplinary teamwork, and continuously evolves through research and teaching. This rich blend of experience reinforces her status as a leader in therapeutic cardiac rehabilitation.

Research Interests

Karolini Branco’s research interests are deeply rooted in improving patient outcomes following cardiac events and surgical interventions, with a specific emphasis on respiratory physiotherapy. She is particularly focused on developing, testing, and validating physiotherapeutic interventions that reduce postoperative pulmonary complications and enhance cardiopulmonary function. One of her key research areas includes the Thoracoabdominal Rebalancing Method (RTA), which she investigates as a superior approach to conventional physiotherapy for patients undergoing coronary artery bypass grafting surgery. Additionally, she explores the role of pulmonary impedance as an innovative marker for assessing therapeutic efficacy in obstructive ventilatory disorders. Karolini has also contributed to pediatric research through a systematic review of equations used to predict maximum heart rate in non-athletic children. Her interests span across intensive care rehabilitation, hemodynamic monitoring, non-invasive respiratory techniques, and the integration of personalized rehabilitation protocols into standard post-surgical care. By targeting physiotherapy’s intersection with clinical cardiology, Karolini aims to establish protocols that are both evidence-based and patient-specific. Her PhD research continues to build upon these themes, with the overarching goal of transforming post-cardiac surgery care to minimize complications, accelerate recovery, and improve patients’ quality of life through physiotherapeutic innovation.

Research Skills

Karolini Branco brings a robust suite of research skills that reflect her dual expertise as a clinician and a scientific investigator. She is proficient in designing and conducting randomized clinical trials, a skill evidenced by her work comparing the Thoracoabdominal Rebalancing Method with conventional physiotherapy in cardiac surgery patients. Her ability to manage all stages of research—from proposal writing, ethical approvals, and recruitment to data collection, analysis, and publication—demonstrates high-level competence in applied health research. She is skilled in systematic literature reviews, quantitative data analysis, and evidence synthesis, which supports her work in pediatric cardiopulmonary assessment and adult rehabilitation techniques. Karolini is also adept at utilizing clinical metrics such as hemodynamic variables, pulmonary impedance, and respiratory function indices for research outcomes. Her close collaboration with medical teams allows her to effectively translate research findings into clinical practice, enhancing real-world impact. Moreover, her teaching roles in academic and residency settings underscore her communication and knowledge dissemination skills, both critical for research leadership. Her ongoing doctoral training further hones her expertise in advanced methodologies and fosters a deeper understanding of translational science in cardiology. Collectively, Karolini’s research skills position her as a dynamic and competent investigator in health sciences.

Awards and Honors

While specific awards and honors are not explicitly listed in the provided profile, Karolini Branco’s professional and academic journey strongly suggests a trajectory deserving of recognition. Her selection into a Multiprofessional Residency in Cardiology at the RS Cardiology Institute—a highly competitive and prestigious program—marks a significant early-career achievement. Her continued acceptance into both a Master’s and PhD program in Cardiology at the same institute further reflects academic merit and the trust of her mentors and institution in her capabilities. Moreover, her work on high-impact randomized clinical trials and systematic reviews demonstrates a level of scholarly contribution that is typically recognized in academic and professional circles. Participation in such research projects and her leadership in clinical implementation signal the likelihood of departmental or institutional accolades. Karolini’s teaching contributions in universities and residencies also suggest recognition as a mentor and educator. Her research’s practical application in improving patient outcomes post-cardiac surgery makes her a strong contender for honors like the Best Researcher Award, especially given her multidisciplinary integration and innovation. As her PhD progresses and her international visibility grows, she is poised to receive further formal recognition for her valuable contributions to health science and cardiopulmonary rehabilitation.

Conclusion

Karolini Branco stands out as a highly capable and impactful physiotherapist whose clinical insight and research innovation significantly contribute to the field of cardiopulmonary rehabilitation. Her academic progression—from bachelor’s to PhD—demonstrates a consistent commitment to advancing healthcare through specialized knowledge and evidence-based practices. Her dual roles in clinical care and academic instruction highlight her versatility and dedication to both patient well-being and professional development within her field. Through her research on thoracoabdominal rebalancing, pulmonary function, and postoperative care, Karolini addresses real-world challenges in critical care and surgery recovery. She brings a strong blend of analytical, procedural, and collaborative skills, which are crucial for multidisciplinary clinical research. Her background indicates a strong capacity for leadership in both academic and hospital environments, and her future contributions are likely to further shape cardiopulmonary physiotherapy standards. With a growing portfolio of impactful studies, teaching roles, and specialized expertise, Karolini is not only deserving of recognition like the Best Researcher Award but also positioned to influence national and international best practices in her domain. As she continues her doctoral work and expands her scholarly influence, she remains a promising figure in advancing health outcomes for cardiac patients through physiotherapy-driven solutions.

Publications Top Notes

  1. Title: Thoracic‐Abdominal Rebalancing Method is Superior in Terms of Decreasing Respiratory Distress, Postoperative Pulmonary Complications and Hemodynamic Variables When Compared to Conventional Physiotherapy in Postoperative Patients of Coronary Artery Bypass Grafting Surgery: Randomized Clinical Trial
    Authors: Karolini Reis Branco, Fernanda dos Santos Silveira, Letícia Ferronato, Simone Cristina Jabuonski, Vinícius Serra Peringer, Mariangela Pinheiro de Lima, João Paulo Heinzmann‐Filho, Bruna Eibel
    Year: 2025

  2. Title: Impedância pulmonar como novo marcador de fisioterapia respiratória em adultos com distúrbios ventilatórios obstrutivos
    Authors: Dyovana Silva Dos Santos, Andressa Schenkel Spitznagel, Karolini Reis Branco, Márcio Vinícius Fagundes Donadio, Camila Isabel Santos Schivinski, Daniele Schiwe, João Paulo Heinzmann Filho
    Year: 2019

  3. Title: Equações utilizadas para a predição de frequência cardíaca máxima na população pediátrica não atlética: uma revisão sistemática
    Year: 2019